,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,880,2,1,,29215265,6057,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
1,880,2,1,,29215265,6057,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
2,881,2,2,,29215265,6057,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
3,894,2,1,,29215265,6057,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
4,1030,2,1,,29215265,6057,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
5,1195,1,2,,48416689,6057,Active,,,,,DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database,Other,,
6,1379,1,2,,29215265,6057,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
7,1452,1,1,,29215265,6057,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
8,1457,1,1,,29215265,6057,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
9,1460,1,3,,29215265,6057,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
10,1463,1,1,,29215265,6057,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
11,1467,1,3,,29215265,6057,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
12,1468,1,1,,29215265,6057,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
13,1469,1,1,,29215265,6057,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
14,1471,2,1,,29215265,6057,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
15,1476,2,1,,29215265,6057,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
16,1477,1,1,,29215265,6057,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
17,1478,2,1,,29215265,6057,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
18,1479,1,2,,29215265,6057,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
19,1487,1,1,,29215265,6057,Inconclusive,27436948.0,4000.0,,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
20,1490,2,1,,29215265,6057,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
21,1576,1,1,,57244288,6057,Inactive,,,,,DSSTox (KIERBL) EPA Estrogen Receptor Ki Binding Study (Laws et al.) Database,Other,,
22,1688,1,1,,29215265,6057,Inactive,90903231.0,3064.0,,Potency,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP),Confirmatory,,
23,1766,1,1,,29215265,6057,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
24,1766,1,1,,29215265,6057,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
25,1768,1,1,,29215265,6057,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
26,1768,1,1,,29215265,6057,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
27,1811,3,2,,46394031,6057,Active,157881611.0,,,,Experimentally measured binding affinity data derived from PDB,Other,8622937.0,
28,1811,3,2,,46394400,6057,Active,231099.0,,,,Experimentally measured binding affinity data derived from PDB,Other,3612807.0,
29,1865,1,1,,29215265,6057,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
30,1948,1,1,,29215265,6057,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
31,2101,1,1,,29215265,6057,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
32,2107,1,1,,29215265,6057,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
33,2112,1,1,,29215265,6057,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
34,2314,1,2,,29215265,6057,Inactive,32400299.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
35,2314,1,2,,29215265,6057,Inactive,32400300.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
36,2315,1,2,,29215265,6057,Inactive,32400299.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
37,2315,1,2,,29215265,6057,Inactive,32400300.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
38,2451,1,2,,29215265,6057,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
39,2472,1,2,,29215265,6057,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
40,2517,2,1,,144205147,6057,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
41,2528,1,2,,29215265,6057,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
42,2546,1,1,,29215265,6057,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
43,2549,1,1,,29215265,6057,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
44,2551,1,1,,29215265,6057,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
45,2662,2,1,,29215265,6057,Inactive,56550039.0,4297.0,,Potency,qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction,Confirmatory,,
46,24263,5,2,,103241488,6057,Unspecified,,,,,"Ability to undergo in vitro ester hydrolysis in 80% human plasma ( pH of 7.4) at 37 degree Celsius expressed as half life of N,N-diethylglycolamide ester hydrolysis",Other,3820215.0,
47,24265,3,4,,103241488,6057,Unspecified,,,,,Ability to undergo in vitro ester hydrolysis in 80% human plasma ( pH of 7.4) at 37 degree Celsius expressed as half life of methyl ester hydrolysis,Other,3820215.0,
48,26797,4,1,,103241488,6057,Unspecified,,,,,Partition coefficient (logP),Other,3656360.0,
49,233318,3,3,,103241488,6057,Unspecified,,,,,Bitter threshold value,Other,3656360.0,
50,274648,3,9,,103241488,6057,Inactive,729887.0,1445.0,,,Inhibition of CSK measured as poly-E4Y phosphorylation by acid precipitation assay in presence of 0.2 mM CoCl2 upto 1000 uM,Other,17149882.0,
51,291061,7,1,,103241488,6057,Active,115449.0,759.0,,,Activation of human recombinant CA1 by CO2 hydrase assay,Other,17540561.0,
52,291063,7,1,,103241488,6057,Active,115456.0,760.0,,,Activation of human recombinant CA2 by CO2 hydrase assay,Other,17540561.0,
53,291065,7,1,,103241488,6057,Active,1168744.0,766.0,,,Activation of human recombinant CA7 by CO2 hydrase assay,Other,17540561.0,
54,291067,7,1,,103241488,6057,Active,8928036.0,23632.0,,,Activation of of human recombinant CA14 by CO2 hydrase assay,Other,17540561.0,
55,305774,7,1,,103241488,6057,Active,115449.0,759.0,,,Activation of human recombinant carbonic anhydrase 1 by stopped-flow CO2 hydrase method,Other,17174092.0,
56,305775,7,1,,103241488,6057,Active,115456.0,760.0,,,Activation of human recombinant carbonic anhydrase 2 by stopped-flow CO2 hydrase method,Other,17174092.0,
57,305776,7,1,,103241488,6057,Active,461680.0,763.0,,,Activation of human recombinant carbonic anhydrase 5A by stopped-flow CO2 hydrase method,Other,17174092.0,
58,305777,7,1,,103241488,6057,Active,8928041.0,11238.0,,,Activation of human recombinant carbonic anhydrase 5B by stopped-flow CO2 hydrase method,Other,17174092.0,
59,307896,7,1,,103241488,6057,Active,115449.0,759.0,,,Activation of human recombinant CA1 by stopped flow CO2 hydrase method,Other,17499996.0,
60,307897,7,1,,103241488,6057,Active,115456.0,760.0,,,Activation of human recombinant CA2 by stopped flow CO2 hydrase method,Other,17499996.0,
61,307898,7,1,,103241488,6057,Active,116241278.0,765.0,,,Activation of human recombinant CA6 by stopped flow CO2 hydrase method,Other,17499996.0,
62,318343,7,1,,103241488,6057,Active,115449.0,759.0,,,Activation of human recombinant CA1 by stopped-flow CO2 hydration method,Other,18294854.0,
63,318344,7,1,,103241488,6057,Active,115456.0,760.0,,,Activation of human recombinant CA2 by stopped-flow CO2 hydration method,Other,18294854.0,
64,318345,7,1,,103241488,6057,Active,83300925.0,768.0,,,Activation of human recombinant CA9 catalytic domain by stopped-flow CO2 hydration method,Other,18294854.0,
65,318346,7,1,,103241488,6057,Active,5915866.0,771.0,,,Activation of human recombinant CA12 catalytic domain by stopped-flow CO2 hydration method,Other,18294854.0,
66,365827,7,1,,103241488,6057,Active,115449.0,759.0,,,Activation of human recombinant CA1 at 10 uM by stopped-flow CO2 hydration method,Other,18627905.0,
67,365828,7,1,,103241488,6057,Active,115456.0,760.0,,,Activation of human recombinant CA2 at 10 uM by stopped-flow CO2 hydration method,Other,18627905.0,
68,365829,7,1,,103241488,6057,Active,134047703.0,761.0,,,Activation of human recombinant CA3 at 10 uM by stopped-flow CO2 hydration method,Other,18627905.0,
69,365830,7,1,,103241488,6057,Active,115465.0,762.0,,,Activation of human recombinant truncated CA4 at 10 uM by stopped-flow CO2 hydration method,Other,18627905.0,
70,375786,7,1,,103241488,6057,Active,115465.0,762.0,,,Activation of human recombinant carbonic anhydrase 4 lacking 20 amino terminal residues by stopped-flow CO2 hydrase method,Other,19464888.0,
71,375787,7,1,,103241488,6057,Active,30580362.0,80733.0,,,Activation of membrane associated mouse recombinant carbonic anhydrase 15 isoform by stopped-flow CO2 hydrase method,Other,19464888.0,
72,403761,3,10,,103241488,6057,Unspecified,6686057.0,,,,Activity of mushroom tyrosinase assessed as specific activity pkat per mg of protein,Other,16180811.0,
73,409983,7,1,,103241488,6057,Unspecified,115449.0,759.0,,,Activity of human recombinant CA1 at 10 uM,Other,18930395.0,
74,409984,7,1,,103241488,6057,Active,115449.0,759.0,,,Activation of human recombinant CA1 by stopped-flow CO2 hydrase assay,Other,18930395.0,
75,409985,7,1,,103241488,6057,Unspecified,115456.0,760.0,,,Activity at human recombinant CA2 at 10 uM,Other,18930395.0,
76,409986,7,1,,103241488,6057,Active,115456.0,760.0,,,Activation of human recombinant CA2 by stopped-flow CO2 hydrase assay,Other,18930395.0,
77,409987,7,1,,103241488,6057,Unspecified,,,,,Activity at Methanobacterium thermoautotrophicum beta-class CA at 10 uM,Other,18930395.0,
78,409988,7,1,,103241488,6057,Active,,,,,Activation of Methanobacterium thermoautotrophicum beta-class CA by stopped-flow CO2 hydrase assay,Other,18930395.0,
79,409989,7,1,,103241488,6057,Unspecified,,,,,Activity at Methanosarcina thermophila Zinc(2)-derived gamma-class CA at 10 uM,Other,18930395.0,
80,409990,7,1,,103241488,6057,Active,,,,,Activation of Methanosarcina thermophila Zinc(2)-derived gamma-class CA by stopped-flow CO2 hydrase assay,Other,18930395.0,
81,409991,7,1,,103241488,6057,Unspecified,,,,,Activity at Methanosarcina thermophila cobalt(2)-derived gamma-class CA at 10 uM,Other,18930395.0,
82,409992,7,1,,103241488,6057,Unspecified,,,,,Activation of Methanosarcina thermophila cobalt(2)-derived gamma-class CA by stopped-flow CO2 hydrase assay,Other,18930395.0,
83,409993,7,1,,103241488,6057,Active,134047703.0,761.0,,,Activation of human recombinant CA3 by stopped-flow CO2 hydrase assay,Other,18930395.0,
84,414329,7,1,,103241488,6057,Active,115456.0,760.0,,,Activation of human recombinant CA2 by stopped-flow CO2 hydrase method,Other,19231177.0,
85,414330,7,1,,103241488,6057,Active,,,,,Activation of Methanothermobacter thermautotrophicus recombinant Cab by stopped-flow CO2 hydrase method,Other,19231177.0,
86,414331,7,1,,103241488,6057,Unspecified,1709238.0,855692.0,,,Activation of yeast recombinant CA by stopped-flow CO2 hydrase method,Other,19231177.0,
87,422805,3,3,,103241488,6057,Inactive,,,,,Activity at 1.62 uM Aspergillus fumigatus CdpNPT assessed as compound conversion rate at 1 mM after 2 hrs by HPLC analysis in presence of dimethylallyl diphosphate,Other,19113967.0,
88,422806,3,9,,103241488,6057,Inactive,550540876.0,,,,Activity at 1.12 uM Aspergillus fumigatus FtmPT1 assessed as compound conversion rate at 1 mM after 16 hrs by HPLC analysis in presence of dimethylallyl diphosphate,Other,19113967.0,
89,436236,3,3,,103241488,6057,Inactive,,,,,"Antiinflammatory activity against trinitrobenzenesulfonic acid-induced colitis in Wistar rat at 100 mg/kg, po",Other,19442419.0,
90,436238,3,3,,103241488,6057,Active,,,,,"Antiinflammatory activity against trinitrobenzenesulfonic acid-induced colitis in Wistar rat at 100 mg/kg, administered rectally in presence of 5-aminosalicylic acid",Other,19442419.0,
91,436240,3,3,,103241488,6057,Inactive,,,,,"Antiinflammatory activity against trinitrobenzenesulfonic acid-induced colitis in Wistar rat assessed as decrease in inflammatory cell infiltration at 100 mg/kg, po measured 24 hrs after last dose on day 11 by haematoxylin/eosin staining",Other,19442419.0,
92,436241,3,3,,103241488,6057,Inactive,,,,,"Antiinflammatory activity against trinitrobenzenesulfonic acid-induced colitis in Wistar rat assessed as decrease in appearance of mucosal abscess at 100 mg/kg, po measured 24 hrs after last dose on day 11 by haematoxylin/eosin staining",Other,19442419.0,
93,436243,3,3,,103241488,6057,Active,,,,,Antiinflammatory activity against trinitrobenzenesulfonic acid-induced colitis in Wistar rat assessed as decrease in appearance of mucosal abscess at 100 mg/kg administered rectally measured 24 hrs after last dose on day 11 by haematoxylin/eosin staining,Other,19442419.0,
94,436244,3,3,,103241488,6057,Active,,,,,Antiinflammatory activity against trinitrobenzenesulfonic acid-induced colitis in Wistar rat assessed as decrease in inflammatory cell infiltration at 100 mg/kg administered rectally measured 24 hrs after last dose on day 11 by haematoxylin/eosin staining in presence of sulfasalazine,Other,19442419.0,
95,458784,3,10,,103241488,6057,Active,74656605.0,3636621.0,,,Activation of Candida albicans beta-carbonic anhydrase Nce103 by stopped flow CO2 hydration assay,Other,20061162.0,
96,458787,3,3,,103241488,6057,Active,,,,,Activation of Cryptococcus neoformans beta-carbonic anhydrase Can2 by stopped flow CO2 hydration assay,Other,20061162.0,
97,462829,3,9,,103241488,6057,Active,115449.0,759.0,,,Activation of human recombinant CA1 by stopped flow CO2 hydration assay,Other,20176489.0,
98,462830,3,9,,103241488,6057,Active,115456.0,760.0,,,Activation of human recombinant CA2by stopped flow CO2 hydration assay,Other,20176489.0,
99,462831,3,9,,103241488,6057,Active,116241278.0,765.0,,,Activation of human full length CA6 by stopped flow CO2 hydration assay,Other,20176489.0,
100,462832,3,3,,103241488,6057,Active,,,,,Activation of Stylophora pistillata carbonic anhydrase STPCA by stopped flow CO2 hydration assay,Other,20176489.0,
101,464319,3,9,,103241488,6057,Active,115456.0,760.0,,,Activation of human recombinant carbonic anhydrase isoenzyme 2 by stopped flow CO2 hydration method,Other,20129782.0,
102,464320,3,7,,103241488,6057,Active,,,,,Activation of archaea Methanobacterium thermoautotrophicum recombinant carbonic anhydrase by stopped flow CO2 hydration method,Other,20129782.0,
103,464321,3,9,,103241488,6057,Unspecified,1709238.0,855692.0,,,Activation of Saccharomyces cerevisiae recombinant Nce103p by stopped flow CO2 hydration method,Other,20129782.0,
104,464322,3,9,,103241488,6057,Active,74610182.0,,,,Activation of Candida glabrata recombinant carbonic anhydrase by stopped flow CO2 hydration method,Other,20129782.0,
105,485281,1,1,,29215265,6057,Inactive,254220970.0,,,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
106,485290,1,1,,29215265,6057,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
107,492961,1,1,,29215265,6057,Inactive,72386991.0,3656265.0,,Potency,qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase: hit validation,Confirmatory,,
108,500825,2,3,,103241488,6057,Active,,,,,Induction of nitrogen-starved wild type sigma1278b yeast Gap1-mediated trehalose activation at 10 mM,Other,19060912.0,
109,504327,1,1,,29215265,6057,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
110,504332,1,1,,29215265,6057,Inactive,168985070.0,,,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
111,504749,1,3,,29215265,6057,Unspecified,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
112,504749,1,3,1.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
113,504749,1,3,2.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
114,504749,1,3,3.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
115,504749,1,3,4.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
116,504749,1,3,5.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
117,504749,1,3,6.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
118,504749,1,3,7.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
119,504749,1,3,8.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
120,504749,1,3,9.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
121,504749,1,3,10.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
122,504749,1,3,11.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
123,504749,1,3,12.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
124,504749,1,3,13.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
125,504749,1,3,14.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
126,504749,1,3,15.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
127,504749,1,3,16.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
128,504749,1,3,17.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
129,504749,1,3,18.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
130,504749,1,3,19.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
131,504749,1,3,20.0,29215265,6057,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
132,504749,1,3,21.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
133,504749,1,3,22.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
134,504749,1,3,23.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
135,504749,1,3,24.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
136,504749,1,3,25.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
137,504749,1,3,26.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
138,504749,1,3,27.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
139,504749,1,3,28.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
140,504749,1,3,29.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
141,504749,1,3,30.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
142,504749,1,3,31.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
143,504749,1,3,32.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
144,504749,1,3,33.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
145,504749,1,3,34.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
146,504749,1,3,35.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
147,504749,1,3,36.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
148,504749,1,3,37.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
149,504749,1,3,38.0,29215265,6057,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
150,504749,1,3,39.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
151,504749,1,3,40.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
152,504749,1,3,41.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
153,504749,1,3,42.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
154,504749,1,3,43.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
155,504749,1,3,44.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
156,504749,1,3,45.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
157,504749,1,3,46.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
158,504749,1,3,47.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
159,504749,1,3,48.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
160,504749,1,3,49.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
161,504749,1,3,50.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
162,504749,1,3,51.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
163,504749,1,3,52.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
164,504749,1,3,53.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
165,504749,1,3,54.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
166,504749,1,3,55.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
167,504749,1,3,56.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
168,504749,1,3,57.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
169,504749,1,3,58.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
170,504749,1,3,59.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
171,504749,1,3,60.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
172,504749,1,3,61.0,29215265,6057,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
173,504832,1,1,,29215265,6057,Inactive,,,,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
174,504834,1,1,,29215265,6057,Inconclusive,,,4.7755,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
175,504847,1,1,,29215265,6057,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
176,504865,1,1,,29215265,6057,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
177,588579,1,1,,29215265,6057,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
178,588834,2,1,,144205147,6057,Inactive,325651834.0,3757.0,,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
179,602332,1,1,,29215265,6057,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
180,624030,1,2,,29215265,6057,Inactive,160794.0,,,Potency,Biochemical firefly luciferase enzyme assay for NPC,Confirmatory,,
181,624031,1,2,,29215265,6057,Inactive,,,,Potency,S16 Schwann cell viability assay (CellTiter-Glo assay),Confirmatory,,
182,624032,1,2,,29215265,6057,Inactive,8393992.0,24660.0,,Potency,S16 Schwann cell PMP22 intronic element firefly luciferase assay,Confirmatory,,
183,624044,1,2,,29215265,6057,Inactive,8393992.0,24660.0,,Potency,S16 Schwann cell PMP22 intronic element beta-lactamase assay,Confirmatory,,
184,624170,1,1,,29215265,6057,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
185,624172,1,1,,29215265,6057,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
186,624173,1,3,,29215265,6057,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
187,624296,1,1,,29215265,6057,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
188,624297,1,1,,29215265,6057,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
189,651631,4,1,,144205147,6057,Inactive,269849759.0,7157.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
190,651632,4,1,,144205147,6057,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
191,651633,4,1,,144205147,6057,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
192,651634,4,1,,144205147,6057,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
193,652048,1,2,,144205147,6057,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
194,652051,1,1,,144205147,6057,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
195,681113,3,6,,103241488,6057,Unspecified,81871541.0,170566.0,,Ki,TP_TRANSPORTER: inhibition of L-tryptophan uptake in Xenopus laevis oocytes,Confirmatory,11278508.0,
196,681145,2,7,,103241488,6057,Unspecified,121945115.0,,636.3,Km,TP_TRANSPORTER: uptake in Xenopus laevis oocytes,Confirmatory,11827462.0,
197,681161,1,7,,103241488,6057,Unspecified,121945115.0,,,,TP_TRANSPORTER: inhibition of L-tryptophan uptake in Xenopus laevis oocytes,Other,11827462.0,
198,681174,2,7,,103241488,6057,Unspecified,81871342.0,259248.0,,Km,TP_TRANSPORTER: uptake in Xenopus laevis oocytes,Confirmatory,12871948.0,
199,681236,1,7,,103241488,6057,Unspecified,81871342.0,259248.0,,,"TP_TRANSPORTER: inhibition of thyroxine uptake (thyroxine:10nM, Tyrosine: 100 uM) in Xenopus laevis oocytes",Other,12871948.0,
200,681245,1,7,,103241488,6057,Unspecified,81871342.0,259248.0,,,"TP_TRANSPORTER: inhibition of 3,3',5-triiodothyronine uptake (3,3',5-triiodothyronine:10nM, Tyrosine: 100 uM) in Xenopus laevis oocytes",Other,12871948.0,
201,686978,1,1,,144205147,6057,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
202,686979,1,1,,144205147,6057,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
203,691713,1,7,,103241488,6057,Active,115449.0,759.0,,,Activity of human recombinant CA1 cytosolic isoform after 15 mins by phenol red staining based stopped flow CO2 hydration assay,Other,22999416.0,
204,691714,1,7,,103241488,6057,Active,115456.0,760.0,,,Activity of human recombinant CA2 cytosolic isoform after 15 mins by phenol red staining based stopped flow CO2 hydration assay,Other,22999416.0,
205,691715,1,2,,103241488,6057,Active,,,,,Activity of Sulfurihydrogenibium yellowstonense YO3AOP1 recombinant CA expressed in Escherichia coli BL21(DE3) after 15 mins by phenol red staining based stopped flow CO2 hydration assay,Other,22999416.0,
206,720516,2,1,,144205147,6057,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
207,720532,1,1,,144205147,6057,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
208,720533,1,1,,144205147,6057,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
209,720552,2,1,,144205147,6057,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
210,720634,2,1,,144205147,6057,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
211,720635,2,1,,144205147,6057,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
212,720637,2,1,,144205147,6057,Inactive,,,,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
213,720674,2,2,,144205147,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
214,720675,2,2,,144205147,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
215,720678,2,1,,144205147,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
216,720679,2,1,,144205147,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
217,720680,2,1,,144205147,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
218,720681,2,1,,144205147,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
219,720682,2,1,,144205147,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
220,720683,2,1,,144205147,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
221,720684,2,1,,144205147,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
222,720685,2,1,,144205147,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
223,720686,2,1,,144205147,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
224,720687,2,2,,144205147,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
225,720691,4,1,,144205147,6057,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
226,720692,3,1,,144205147,6057,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
227,720693,3,1,,144205147,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
228,720719,2,1,,144205147,6057,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
229,720725,2,1,,144205147,6057,Inactive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
230,725226,1,2,,103241488,6057,Active,,,,,Activation of Sulfurihydrogenibium azorense recombinant alpha carbonic anhydrase by stopped flow CO2 hydrase method,Other,23294703.0,
231,725227,1,2,,103241488,6057,Active,,,,,Activation of Sulfurihydrogenibium yellowstonense recombinant CA by stopped flow CO2 hydrase method,Other,23294703.0,
232,725228,1,6,,103241488,6057,Active,115449.0,759.0,,,Activation of human recombinant CA1 by stopped flow CO2 hydrase method,Other,23294703.0,
233,725229,1,6,,103241488,6057,Active,115456.0,760.0,,,Activation of human recombinant CA2 by stopped flow CO2 hydrase method,Other,23294703.0,
234,738129,2,5,,103241488,6057,Inactive,129825.0,4353.0,,IC50,Inhibition of human recombinant MPO-mediated taurine chlorination after 5 mins by microplate assay,Confirmatory,23581551.0,
235,743012,3,1,,144205147,6057,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
236,743014,3,1,,144205147,6057,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
237,743015,3,1,,144205147,6057,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
238,743033,3,1,,144205147,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
239,743035,2,1,,144205147,6057,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
240,743036,2,1,,144205147,6057,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
241,743040,3,1,,144205147,6057,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
242,743041,3,1,,144205147,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
243,743042,3,1,,144205147,6057,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
244,743053,2,1,,144205147,6057,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
245,743054,2,1,,144205147,6057,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
246,743063,2,1,,144205147,6057,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
247,743064,3,1,,144205147,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
248,743065,3,1,,144205147,6057,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
249,743066,3,1,,144205147,6057,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
250,743067,2,1,,144205147,6057,Inactive,399498506.0,24831.0,,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
251,743069,2,1,,144205147,6057,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
252,743074,2,1,,144205147,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
253,743075,2,1,,144205147,6057,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
254,743077,2,1,,144205147,6057,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
255,743078,2,1,,144205147,6057,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
256,743079,3,1,,144205147,6057,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
257,743080,3,1,,144205147,6057,Inactive,348019627.0,2099.0,33.4915,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
258,743081,3,1,,144205147,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
259,743083,3,1,,144205147,6057,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
260,743084,3,1,,144205147,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
261,743085,3,1,,144205147,6057,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
262,743086,3,1,,144205147,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
263,743091,2,1,,144205147,6057,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
264,743094,3,1,,144205147,6057,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
265,743122,2,1,,144205147,6057,Inactive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
266,743139,2,1,,144205147,6057,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
267,743140,2,1,,144205147,6057,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
268,743191,3,1,,170466853,6057,Inconclusive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
269,743194,3,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
270,743199,2,1,,170466853,6057,Inactive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
271,743202,4,1,,170466853,6057,Inactive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
272,743203,3,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
273,743209,3,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
274,743210,4,1,,170466853,6057,Inactive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
275,743211,3,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
276,743212,3,1,,170466853,6057,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
277,743213,3,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
278,743215,3,1,,170466853,6057,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
279,743217,3,1,,170466853,6057,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
280,743218,3,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
281,743219,3,1,,170466853,6057,Inactive,20149576.0,4780.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
282,743220,3,1,,170466853,6057,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
283,743221,3,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
284,743222,3,1,,170466853,6057,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
285,743223,3,1,,170466853,6057,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
286,743224,3,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
287,743225,3,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
288,743226,2,1,,170466853,6057,Inactive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
289,743227,2,1,,170466853,6057,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
290,743228,3,1,,170466853,6057,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
291,743239,2,1,,170466853,6057,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
292,743240,2,1,,170466853,6057,Inactive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
293,743241,2,1,,170466853,6057,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
294,743242,2,1,,170466853,6057,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
295,743244,1,1,,144205147,6057,Inactive,,,,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
296,781325,1,2,,103241488,6057,Unspecified,,,,,pKa (acid-base dissociation constant) as determined by Liao ref: J Chem Info Model 2009,Other,24249037.0,
297,781326,1,2,,103241488,6057,Unspecified,,,,,pKa (acid-base dissociation constant) as determined by Avdeef ref: DOI: 10.1002/047145026X,Other,24249037.0,
298,977610,3,1,,46394031,6057,Active,313507253.0,,50.0,Ki,Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB,Other,8622937.0,
299,977611,3,1,,46394400,6057,Active,231099.0,,11.6,Kd,Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB,Other,3612807.0,
300,1054224,1,1,,103241488,6057,Unspecified,,,250.0,Km,Activity at mushroom tyrosinase by Michaelis-Menten plot analysis,Confirmatory,24125877.0,
301,1117298,1,2,,170466853,6057,Inactive,,,1.9953,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 green channel",Confirmatory,,
302,1117304,1,2,,170466853,6057,Inactive,,,2.2387,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 blue channel",Confirmatory,,
303,1117305,1,2,,170466853,6057,Inactive,,,7.0795,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 ratio channel",Confirmatory,,
304,1117310,1,1,,170466853,6057,Inactive,,,1.9952599999999998,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, green channel",Confirmatory,,
305,1117312,1,1,,170466853,6057,Inactive,,,7.079460000000001,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen2, ratio channel",Confirmatory,,
306,1117314,1,1,,170466853,6057,Inactive,,,2.2387200000000003,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, blue channel",Confirmatory,,
307,1117326,1,1,,170466853,6057,Inactive,,,,,nuclear beta catenin stimulation in WNT3A conditioned C2C12 cells-screen,Screening,,
308,1117329,1,1,,170466853,6057,Inactive,,,,,insulin secretion from INS-1E cells in the presence of 5 mM glucose-screen,Screening,,
309,1117336,1,1,,170466853,6057,Inactive,,,,,GSK3B-pretreated HCT116 viability from Cell TiterGlo-screen,Screening,,
310,1117340,1,1,,170466853,6057,Inactive,,,,,VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area decrease-screen,Screening,,
311,1117341,1,1,,170466853,6057,Inactive,,,,,GLP1 secretion from NCI-H716 cells-screen,Screening,,
312,1117342,1,1,,170466853,6057,Inactive,,,,,HCT116 viability from Cell TiterGlo-screen,Screening,,
313,1117343,1,1,,170466853,6057,Inactive,,,,,SW480 viability from Cell TiterGlo-screen,Screening,,
314,1117346,1,1,,170466853,6057,Inactive,,,,,DLD-1 viability from Cell TiterGlo-screen,Screening,,
315,1159509,1,1,,170466853,6057,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
316,1159515,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
317,1159516,1,1,,170466853,6057,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
318,1159517,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
319,1159518,1,1,,170466853,6057,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
320,1159519,1,1,,170466853,6057,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
321,1159520,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
322,1159521,1,1,,170466853,6057,Inactive,15928672.0,19885.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
323,1159523,1,1,,170466853,6057,Inactive,15928672.0,19885.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
324,1159525,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
325,1159526,1,1,,170466853,6057,Inactive,119627033.0,3725.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
326,1159527,1,1,,170466853,6057,Inactive,325495497.0,6256.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
327,1159528,1,1,,170466853,6057,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
328,1159529,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
329,1159531,1,1,,170466853,6057,Inactive,325495497.0,6256.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
330,1159551,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
331,1159552,1,1,,170466853,6057,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
332,1159553,2,1,,170466853,6057,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
333,1159555,1,1,,170466853,6057,Inactive,325495463.0,5914.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
334,1159614,1,2,,170466853,6057,Inactive,22328079.0,2581.0,,Potency,A Novel Cell-Based Assay to Identify Small Molecules for B -Galactocerebrosidase,Confirmatory,,
335,1159620,1,1,,103241488,6057,Active,,,,,Summary of drug indications.,Other,,
336,1194150,1,1,,103241488,6057,Unspecified,,,,,Antioxidant activity assessed as hydroxyl radical scavenging activity by measuring relative rate constant (kAOx/kST ratio) using DMPO spin trap by ESR spin-trapping method,Other,25791448.0,
337,1194151,1,1,,103241488,6057,Unspecified,,,,,Antioxidant activity assessed as rate constant for hydroxyl radical scavenging activity using DMPO spin trap by ESR spin-trapping method,Other,25791448.0,
338,1194152,1,1,,103241488,6057,Unspecified,,,,,Antioxidant activity assessed as superoxide anion radical scavenging activity by measuring relative rate constant (kAOx/kST ratio) using CYPMPO spin trap by ESR spin-trapping method,Other,25791448.0,
339,1194153,1,1,,103241488,6057,Unspecified,,,,,Antioxidant activity assessed as rate constant for superoxide anion radical scavenging activity using CYPMPO spin trap by ESR spin-trapping method,Other,25791448.0,
340,1194154,1,1,,103241488,6057,Unspecified,,,,,Antioxidant activity assessed as alkoxyl radical scavenging activity by measuring relative rate constant (kAOx/kST ratio) using DMPO spin trap by ESR spin-trapping method,Other,25791448.0,
341,1194155,1,1,,103241488,6057,Unspecified,,,,,Antioxidant activity assessed as rate constant for alkoxyl radical scavenging activity using DMPO spin trap by ESR spin-trapping method,Other,25791448.0,
342,1194156,1,1,,103241488,6057,Unspecified,,,,,Antioxidant activity assessed as peroxyl radical scavenging activity by measuring relative rate constant (kAOx/kST ratio) using CYPMPO spin trap by ESR spin-trapping method,Other,25791448.0,
343,1194157,1,1,,103241488,6057,Inconclusive,,,,,Antioxidant activity assessed as rate constant for peroxyl radical scavenging activity using CYPMPO spin trap by ESR spin-trapping method,Other,25791448.0,
344,1194158,1,1,,103241488,6057,Unspecified,,,,,Antioxidant activity assessed as methyl radical scavenging activity by measuring relative rate constant (kAOx/kST ratio) using DMPO spin trap by ESR spin-trapping method,Other,25791448.0,
345,1194159,1,1,,103241488,6057,Unspecified,,,,,Antioxidant activity assessed as rate constant for methyl radical scavenging activity using DMPO spin trap by ESR spin-trapping method,Other,25791448.0,
346,1194160,1,1,,103241488,6057,Unspecified,,,,,Antioxidant activity assessed as singlet oxygen radical scavenging activity by measuring relative rate constant (kAOx/kST ratio) using 4-HO-TEMP spin trap by ESR spin-trapping method,Other,25791448.0,
347,1194161,1,1,,103241488,6057,Unspecified,,,,,Antioxidant activity assessed as rate constant for singlet oxygen radical scavenging activity using 4-HO-TEMP spin trap by ESR spin-trapping method,Other,25791448.0,
348,1224834,3,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
349,1224835,1,1,,170466853,6057,Inactive,160794.0,,,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
350,1224836,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
351,1224837,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
352,1224838,1,1,,170466853,6057,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
353,1224839,1,1,,170466853,6057,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
354,1224840,3,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
355,1224841,3,1,,170466853,6057,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
356,1224842,3,1,,170466853,6057,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
357,1224843,1,1,,170466853,6057,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
358,1224844,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
359,1224845,1,1,,170466853,6057,Inactive,344243002.0,100757539.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
360,1224846,1,1,,170466853,6057,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
361,1224847,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
362,1224848,3,1,,170466853,6057,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
363,1224849,3,1,,170466853,6057,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
364,1224857,2,1,,170466853,6057,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
365,1224859,2,1,,170466853,6057,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
366,1224867,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
367,1224868,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
368,1224869,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
369,1224870,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
370,1224871,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
371,1224872,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
372,1224873,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
373,1224874,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
374,1224875,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
375,1224876,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
376,1224877,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
377,1224878,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
378,1224879,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
379,1224880,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
380,1224881,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
381,1224882,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
382,1224883,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
383,1224884,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
384,1224885,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
385,1224886,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
386,1224887,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
387,1224888,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
388,1224889,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
389,1224890,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
390,1224892,1,1,,170466853,6057,Inactive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
391,1224893,1,1,,170466853,6057,Inactive,66775687.0,9970.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
392,1224894,1,1,,170466853,6057,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
393,1224895,1,1,,170466853,6057,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
394,1224896,1,1,,170466853,6057,Inactive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
395,1256762,1,1,,103241488,6057,Unspecified,,,,,Inhibition of Mycobacterium tuberculosis MTCC 300 DAH7PS expressed in Escherichia coli BL21 (DE3) using 25 to 125 uM PEP/100 uM E4P as substrate at 10 uM by spectrophotometric analysis relative to control,Other,26491981.0,
396,1256763,1,1,,103241488,6057,Active,,,13.0,IC50,Inhibition of Mycobacterium tuberculosis MTCC 300 DAH7PS expressed in Escherichia coli BL21 (DE3) using 25 to 125 uM PEP/100 uM E4P as substrate by spectrophotometric analysis,Confirmatory,26491981.0,
397,1259241,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
398,1259242,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
399,1259243,1,1,,170466853,6057,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
400,1259244,1,1,,170466853,6057,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
401,1259247,1,1,,170466853,6057,Inactive,124375976.0,367.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
402,1259248,1,1,,170466853,6057,Inactive,348019627.0,2099.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
403,1259344,1,1,,144205147,6057,Inactive,,,,Potency,qHTS assay to identify small molecule phospholipidosis (PLD) inducers,Confirmatory,,
404,1259355,1,1,,144205147,6057,Inactive,,,,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-1,Confirmatory,,
405,1259356,1,1,,144205147,6057,Inactive,,,,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-2,Confirmatory,,
406,1259364,1,1,,170466853,6057,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
407,1259365,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
408,1259366,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
409,1259367,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
410,1259368,1,1,,170466853,6057,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
411,1259369,1,1,,170466853,6057,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
412,1259377,1,1,,170466853,6057,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
413,1259378,1,1,,170466853,6057,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
414,1259379,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
415,1259380,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
416,1259381,1,1,,170466853,6057,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
417,1259382,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
418,1259383,1,1,,170466853,6057,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
419,1259384,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
420,1259385,1,1,,170466853,6057,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
421,1259386,1,1,,170466853,6057,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
422,1259387,1,1,,170466853,6057,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
423,1259388,1,1,,170466853,6057,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
424,1259390,1,1,,170466853,6057,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
425,1259391,1,1,,170466853,6057,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
426,1259392,1,1,,170466853,6057,Inactive,109731339.0,2737.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
427,1259393,1,1,,170466853,6057,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
428,1259394,1,1,,170466853,6057,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
429,1259395,1,1,,170466853,6057,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
430,1259396,1,1,,170466853,6057,Inactive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
431,1259400,1,1,,170466853,6057,Inactive,166209887.0,59350.0,,,qHTS Assay for Antagonists of the Relaxin Receptor RXFP1,Screening,,
432,1259401,1,1,,170466853,6057,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
433,1259402,1,1,,170466853,6057,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
434,1259403,1,1,,170466853,6057,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
435,1259404,1,1,,170466853,6057,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
